Can RAGE signaling at the neurovascular unit transport circulating amyloid-beta into the brain and amplify endothelial inflammation and oxidative stress?

RAGE (receptor for advanced glycation end products) is a biologically credible neurovascular pathway linking circulating amyloid-beta (Aβ) with brain Aβ entry and vascular injury. The strongest evidence comes from experimental models; human evidence supports relevance but is largely postmortem and associative.

Transport and amyloid accumulation

• In animal blood–brain barrier (BBB) studies, endothelial/neurovascular RAGE facilitates blood-to-brain Aβ influx. In aged APP-transgenic mice, the RAGE inhibitors FPS-ZM1 and FPS2 reduced Aβ40 influx by 97% and 93%, respectively; FPS-ZM1 also reduced Aβ42 influx.
• A RAGE-blocking antibody that does not enter the brain also inhibited Aβ transport, implicating the blood-facing endothelial RAGE pool.
• RAGE blockade or deletion reduced brain Aβ accumulation in systemic Aβ-infusion and genetically modified mouse experiments. This complements LRP1, generally considered a brain-to-blood Aβ efflux pathway.

Endothelial and vascular effects

• Aβ–RAGE signaling activates NF-κB–dependent endothelial inflammatory signaling and apoptosis in preclinical systems. In APPsw mice, FPS-ZM1 was associated with reduced neuroinflammation and improved cerebral blood-flow responses.
• Experimental evidence also links this pathway to increased BBB permeability and endothelin-1–mediated vasoconstriction, potentially coupling Aβ influx to impaired vascular function.
• Oxidative stress is mechanistically plausible: Aβ can induce NADPH oxidase–dependent reactive oxygen species generation in cerebral endothelial cells, which can reinforce NF-κB activation, inflammation, and barrier injury. However, endothelial-specific RAGE-to-oxidative-stress causality is less directly demonstrated than transport or inflammatory signaling.

Human relevance

• Alzheimer disease postmortem tissue shows increased RAGE in cerebral microvessels/endothelial cells, particularly near amyloid deposits and with greater disease severity, but this does not establish causation in living people.

Bottom line

• The claim is well supported for RAGE-mediated entry of circulating Aβ and for endothelial inflammatory signaling in experimental models; oxidative-stress amplification is credible but less conclusively established. Its quantitative importance in human Alzheimer disease remains uncertain.